Beryl Drugs Limited (BOM:524606)

India · Delayed Price · Currency is INR

25.87

+0.87 (3.48%)

At close: Nov 6, 2026

Market Cap	131.20M +10.1%
Revenue (ttm)	213.23M +8.3%
Net Income	6.25M +169.1%
EPS	n/a
Shares Out	5.07M
PE Ratio	21.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,392
Open	24.99
Previous Close	25.00
Day's Range	23.97 - 26.00
52-Week Range	15.92 - 27.90
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2026

About Beryl Drugs

Beryl Drugs Limited engages in the manufacture and marketing of pharmaceutical products in India. It offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. The company also provides research and development, and contract manufacturing services. It exports its products. The company was incorporated in 1993 and is based in Indore, India. [Read more]

Industry Pharmaceutical Preparations

Founded 1993

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524606

Full Company Profile

Financial Performance

In fiscal year 2026, Beryl Drugs's revenue was 188.20 million, a decrease of -11.00% compared to the previous year's 211.46 million. Earnings were 4.25 million, a decrease of -25.15%.

Financial Statements